Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine.
Department of Public Health, Osaka University Graduate School of Medicine.
Circ J. 2018 Jan 25;82(2):448-456. doi: 10.1253/circj.CJ-17-0541. Epub 2017 Sep 23.
Blood stream infection is thought to increase the risk of hemorrhagic stroke, a major adverse event with devastating outcome, in patients with continuous-flow left ventricular assist devices (LVADs). We analyzed the risk factors of hemorrhagic stroke in LVAD patients, as well as the time relationship between systemic bacteremia and hemorrhagic stroke.Methods and Results:We evaluated the incidence of systemic bacteremia and stroke in 164 patients who underwent continuous-flow LVAD implantation between 2005 and 2016. At 1 and 2 years after implantation, the incidence of bacteremia was 29% and 36%, and the incidence of hemorrhagic stroke was 22% and 22% in patients without bacteremia, and 32% and 44% in those with bacteremia, respectively (P=0.035). This higher prevalence of hemorrhagic stroke in patients with bacteremia was notable particularly in the chronic phase (>90 days after implantation). Multivariate analysis revealed that bacteremia was an independent risk factor of hemorrhagic stroke in the chronic phase [hazard ratio, 2.36 (1.02-5.62); P=0.044]. The hazard rate was the highest immediately after the onset of bacteremia, and the risk steadily declined by 90 days after the last episode of bacteremia and flattened thereafter.
Bacteremia was an independent risk factor of hemorrhagic stroke in patients in the chronic phase, with the highest risk seen in the early phase following an episode of bacteremia.
血流感染被认为会增加持续性左心室辅助装置(LVAD)患者发生出血性卒中的风险,这是一种具有破坏性结局的主要不良事件。我们分析了 LVAD 患者出血性卒中的危险因素,以及全身菌血症与出血性卒中之间的时间关系。
我们评估了 164 例于 2005 年至 2016 年间接受持续性 LVAD 植入术的患者的全身菌血症和卒中发生率。在植入后 1 年和 2 年,无菌血症患者的菌血症发生率分别为 29%和 36%,出血性卒中发生率分别为 22%和 22%;而菌血症患者的发生率分别为 32%和 44%(P=0.035)。菌血症患者出血性卒中的发生率更高,尤其是在慢性期(植入后>90 天)。多变量分析显示,菌血症是慢性期出血性卒中的独立危险因素[风险比,2.36(1.02-5.62);P=0.044]。菌血症发作后立即风险最高,且在最后一次菌血症发作后 90 天风险稳步下降并趋于平稳。
菌血症是慢性期患者出血性卒中的独立危险因素,菌血症发作后早期风险最高。